Abstract:The attrition rate of drugs in clinical trials is generally quite high, with estimates suggesting that approximately 90% of drugs fail to make it through the process. The identification of unexpected toxicity issues during preclinical stages is a significant factor contributing to this high rate of failure. These issues can have a major impact on the success of a drug and must be carefully considered throughout the development process. These late-stage rejections or withdrawals of drug candidates significantly increase the costs associated with drug development, particularly when toxicity is detected during clinical trials or after market release. Understanding drug-biological target interactions is essential for evaluating compound toxicity and safety, as well as predicting therapeutic effects and potential off-target effects that could lead to toxicity. This will enable scientists to predict and assess the safety profiles of drug candidates more accurately. Evaluation of toxicity and safety is a critical aspect of drug development, and biomolecules, particularly proteins, play vital roles in complex biological networks and often serve as targets for various chemicals. Therefore, a better understanding of these interactions is crucial for the advancement of drug development. The development of computational methods for evaluating protein-ligand interactions and predicting toxicity is emerging as a promising approach that adheres to the 3Rs principles (replace, reduce, and refine) and has garnered significant attention in recent years. In this review, we present a thorough examination of the latest breakthroughs in drug toxicity prediction, highlighting the significance of drug-target binding affinity in anticipating and mitigating possible adverse effects. In doing so, we aim to contribute to the development of more effective and secure drugs.

Network medicine and systems pharmacology approaches to predicting adverse drug effects

In Silico Prediction Of Adverse Drug Reactions And Toxicities Based On Structural, Biological And Clinical Data

Predicting Drugs Side Effects Based on Chemical-Chemical Interactions and Protein-Chemical Interactions

A Survey on Computational Approaches to Predicting Adverse Drug Reactions.

Development of an adverse drug event network to predict drug toxicity

Drug target, class level, and PathFX pathway information share utility for machine learning prediction of common drug-induced side effects

Computerized techniques pave the way for drug-drug interaction prediction and interpretation

Drug-Drug Adverse Effect Prediction with Graph Co-Attention

Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects

Drug–drug interaction prediction: databases, web servers and computational models

Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction

Predicting Drug Side Effects Using Data Analytics and the Integration of Multiple Data Sources

Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

Systematic Prediction of Pharmacodynamic Drug-Drug Interactions Through Protein-Protein-Interaction Network.

Computational and artificial intelligence-based approaches for drug metabolism and transport prediction

Systematic Drug Safety Evaluation Based on Public Genomic Expression (connectivity Map) Data: Myocardial and Infectious Adverse Reactions As Application Cases.

Preclinical side effect prediction through pathway engineering of protein interaction network models

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

Network-based Method to Infer the Contributions of Proteins to the Etiology of Drug Side Effects

Data Mining and Analytical Models to Predict and Identify Adverse Drug-drug Interactions